Eukles Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History

Eukles Asset Management’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-205	Closed	-$2.86K	–	257
2023 Q3	$2.86K	Hold	205	–	–	﹤0.01%	195
2023 Q2	$2.41K	Hold	205	–	–	﹤0.01%	200
2023 Q1	$2.36K	Hold	205	–	–	﹤0.01%	187
2022 Q4	$3K	Hold	205	–	–	﹤0.01%	181
2022 Q3	$3K	Hold	205	–	–	﹤0.01%	178
2022 Q2	$3K	Hold	205	–	–	﹤0.01%	179
2022 Q1	$3K	Hold	205	–	–	﹤0.01%	182
2021 Q4	$3K	Hold	205	–	–	﹤0.01%	196
2021 Q3	$3K	Hold	205	–	–	﹤0.01%	186
2021 Q2	$4K	Hold	205	–	–	﹤0.01%	203
2021 Q1	$4K	Hold	205	–	–	﹤0.01%	170
2020 Q4	$4K	Hold	205	–	–	﹤0.01%	140
2020 Q3	$3K	Hold	205	–	–	﹤0.01%	139
2020 Q2	$2K	Hold	205	–	–	﹤0.01%	143
2020 Q1	$2K	Hold	205	–	–	﹤0.01%	134
2019 Q4	$4K	Hold	205	–	–	﹤0.01%	140
2019 Q3	$5K	Hold	205	–	–	﹤0.01%	143
2019 Q2	$4K	Hold	205	–	–	﹤0.01%	148
2019 Q1	$4K	Hold	205	–	–	﹤0.01%	135
2018 Q4	$3K	Buy	+205	New	+$4.13K	﹤0.01%	133

Other funds holding SBRA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Eukles Asset Management's SBRA Position: Q4 2023 in Review

Eukles Asset Management sold out of Sabra Healthcare REIT (SBRA) in Q4 2023, closing a stake of 205 shares — an estimated $2.86K sold.

Eukles Asset Management first reported a position in SBRA in Q4 2018 and held it in 20 quarters. The position peaked at $5K in Q3 2019. 359 funds tracked by Wall St. Rank hold SBRA as of Q4 2023.

Eukles Asset Management reported no remaining Sabra Healthcare REIT position as of Q4 2023 after selling out during the quarter.
Eukles Asset Management sold 205 Sabra Healthcare REIT shares in Q4 2023, an estimated $2.86K.
Eukles Asset Management first reported a position in Sabra Healthcare REIT in Q4 2018 and held it in 20 quarters.
Eukles Asset Management's Sabra Healthcare REIT position peaked at $5K in Q3 2019.
359 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2023.

Based on Eukles Asset Management's 13F filing for Q4 2023, filed 31 Jan 2024.